DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives

Abstract excerpt

Cholangiocarcinoma (CCA) is a poorly treatable type of cancer and its incidence is dramatically increasing. The lack of understanding of the biology of this tumor has slowed down the identification of novel targets and the development of effective treatments. Based on next generation sequencing profiling, alterations in DNA damage response (DDR)-related genes are paving the way for DDR-targeting strategies in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Cholangiocarcinoma and Gallbladder Cancer Studies
• Share to DNA Repair Mechanisms